PDCD1 and pancreatic neoplasm: This concept was further supported by data from a murine model of pancreatic cancer liver metastasis, where the combination of Gemcitabine treatment and anti-PD-1 antibody was associated with infiltration of CD8+ T cells and M1 macrophages along with prolonged survival of the mice (58).